background imageReuters

The deadly drug that’s complicating US-China trade

author image

By illuminem briefings

· 3 min read


illuminem summarises for you the essential news of the day. Read the full piece on CNN or enjoy below:

🗞️ Driving the news: US-China tensions over fentanyl have escalated into a trade dispute, with President Trump maintaining a 20% tariff on all Chinese imports in response to Beijing’s alleged role in the US opioid crisis
• In recent weeks, China has moved to control additional fentanyl precursors and related synthetic opioids, signalling readiness for “practical cooperation” while rejecting US accusations of “poisoning” Americans
• Analysts note Beijing is positioning these moves as goodwill, hoping to leverage them in wider trade and diplomatic talks

🔭 The context: Fentanyl — an ultra-potent synthetic opioid — has fuelled a deadly overdose epidemic in the US. After initial progress following China’s 2019 controls on finished fentanyl, trafficking shifted to precursor chemicals exported to Mexico, where cartels manufacture the drug
• US officials argue Beijing’s enforcement remains inconsistent and insufficient, while China insists it has gone beyond international obligations
• Cooperation has previously been tied to the broader political climate, with past breakdowns over Taiwan and trade disputes.

🌍 Why it matters for the planet: This dispute highlights the intersection of public health, international trade, and governance accountability
• A trade war risks destabilising global supply chains, including sustainable industries, while undermining cooperation on transnational challenges like drug control, climate action, and biodiversity
• Stronger bilateral frameworks on chemical regulation and enforcement could also serve as a model for managing other cross-border environmental and health risks

⏭️ What's next: China’s recent controls on two more precursors and nitazenes appear timed to encourage US reciprocity and to prevent further escalation of tariffs
• Beijing is reportedly keen to secure a diplomatic visit by Trump later this year, framing progress on counternarcotics as part of a broader “package deal” encompassing trade and security
• However, the US administration’s public rhetoric and demands for further Chinese action may stall cooperation if not matched with recognition of Beijing’s steps so far

💬 One quote: “You really can’t solve the fentanyl problem through control alone… the most fundamental issue is still reducing demand,” — Hua Zhendong, deputy director at China’s Ministry of Public Security.

📈 One stat: In 2024 alone, Chinese authorities reported seizing over 1,400 tons of fentanyl precursor chemicals and resolving 151 criminal cases linked to illicit drug production

Explore carbon credit purchases, total emissions, and climate targets of thousands of companies on Data Hub™ — the first platform designed to help sustainability providers generate sales leads!

Click for more news covering the latest on public governance

Did you enjoy this illuminem voice? Support us by sharing this article!
author photo

About the author

illuminem's editorial team, providing you with concise summaries of the most important sustainability news of the day. Follow us on Linkedin, Twitter​ & Instagram

Other illuminem Voices


Related Posts


You cannot miss it!

Weekly. Free. Your Top 10 Sustainability & Energy Posts.

You can unsubscribe at any time (read our privacy policy)